Errors in these modifications can disrupt metabolic processes ... “Our findings could therefore provide new directions for the development of RNA-based therapeutics. It is conceivable that further ...

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

AI and machine learning in RNA therapeutics As we neared the end ... There are more than 100 different types of RNA modifications, but these need to be precisely placed to maximise their impact.

Such modifications have some very important ... could therefore provide new directions for the development of RNA-based therapeutics" says Höbartner. "It is conceivable that further developed ...

Such modifications have some very important ... could therefore provide new directions for the development of RNA-based therapeutics" says Höbartner. "It is conceivable that further developed ...

When Xiao Wang applied to faculty jobs, many of the institutions where she interviewed thought her research proposal - to ...

Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, today announced the full commercial launch of its EpiPlex™ platform, the first to concurrently detect and quantify multiple RNA ...

This fundamental knowledge of how RNA works helped the researchers to find a precise starting point for studying the role of modifications in fungal biology. In the study, the research team first ...

ZWINGENBERG, Germany, Feb. 4, 2025 /PRNewswire/ -- Akribion Therapeutics ("Akribion"), the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell ...

SMi’s 11 th annual RNA Therapeutics conference, taking place on 19 th – 20 th February in London, will bring together industry experts from leading RNA therapeutics companies to discuss the ...